Literature DB >> 1174553

Stimulation by glucagon of the incorporation of U-14C-labeled substrates into glucose by isolated hepatocytes from fed rats.

T H Claus, S J Pilkis, C R Park.   

Abstract

The effect of glucagon on the incorporation of U-14C-labeled lactate, pyruvate or alanine into glucose has been studied using isolated hepatocytes from livers of fed rats. Rates of incorporation into glucose were about the same as observed in perfused liver preparations provided precautions were taken to avoid depletion of certain metabolities by the preparative procedures. With each substrate, stimulation of the incorporation into glucose by a maximally effective concentration of glucagon (10 nM) was associated with about a 75% reduction in the substrate concentration required for a half-maximal rate and with about a 30% increase in maximum rate. Consequently, the hormone caused a substantial (2--4-fold) stimulation when any one of the above substrates was present at a near physiological concentration, but brought about only a relatively small stimulation (1.4-fold) when very high substrate concentrations were used. Provision of cytoplasmic reducing equivalents (by ethanol addition), or of precursor for acetyl-coenzyme A formation (by acetate addition)-stimulated incorporation of labeled alanine into glucose and their effects were additive with that of glucagon. This suggested that provision of either of these intermediates was not a means by which the hormone increased the incorporation of labeled substrate into glucose. NH4+ stimulated the incorporation of 20 mM [U-14C] lactate into glucose 2-fold, probably by promoting glutamate synthesis and thus enhancing the transamination of oxaloacetate to aspartate. Evidence was obtained to support the view that glucagon also increases glutamate production (presumably from endogenous protein). However, the stimulation of incorporation into glucose from 20 mM [U-14C] lactate by NH4+ plus glucagon was synergistic. This suggested that glucagon also stimulated the incorporation of labeled substrate into glucose by additional means. Stimulation of the incorporation of [U-14C] alanine into glucose by beta-hydroxybutyrate plus glucagon was also synergistic. This suggested that another action of glucagon may be to provide more intramitochondrial reducing potential.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174553     DOI: 10.1016/0304-4165(75)90152-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  The metabolic environment of cancer.

Authors:  J M Argilés; J Azcón-Bieto
Journal:  Mol Cell Biochem       Date:  1988-05       Impact factor: 3.396

2.  Hepatic gluconeogenesis in chickens.

Authors:  A J Dickson; D R Langslow
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

3.  Role of fructose 2,6-bisphosphate in the control by glucagon of gluconeogenesis from various precursors in isolated rat hepatocytes.

Authors:  L Hue; R Bartrons
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

4.  Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated hepatocytes.

Authors:  J E Feliú; L Hue; H G Hers
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

5.  Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes.

Authors:  R A Richman; T H Claus; S J Pilkis; D L Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

6.  Effect of glucose on carbohydrate synthesis from alanine or lactate in hepatocytes from starved rats.

Authors:  K Solanki; F Nyfeler; U K Moser; P Walter
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

7.  Lipogenesis and the synthesis and secretion of very low density lipoprotein by avian liver cells in nonproliferating monolayer culture. Hormonal effects.

Authors:  D M Tarlow; P A Watkins; R E Reed; R S Miller; E E Zwergel; M D Lane
Journal:  J Cell Biol       Date:  1977-05       Impact factor: 10.539

8.  AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B.

Authors:  M Johanns; Y-C Lai; M-F Hsu; R Jacobs; D Vertommen; J Van Sande; J E Dumont; A Woods; D Carling; L Hue; B Viollet; M Foretz; M H Rider
Journal:  Nat Commun       Date:  2016-03-08       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.